Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy

Take Me There Now

Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
Open Forum Infectious Diseases | March 26, 2021
Summary

The University of Pittsburgh Medical Center (UPMC) released a study showing that monoclonal antibody therapy can help certain people fight COVID-19 and keep them from progressing to serious illness and death. This study demonstrates how they were able to distribute and administer agents across 35 hospitals, several senior community facilities and skilled nursing facilities (SNF), and numerous outpatient providers. Because administering these infusions comes with logistical challenges, UPMC addresses concerns and shares recommendations in this study including infection prevention measures.

Get Started

Read the study by the University of Pittsburgh here.

Visit bioMérieux's COVID-19 solutions page to learn more about our fast and actionable diagnostics and advanced analytic tools to identify and monitor COVID-19.